Stockscreener 앱 받기
1.44
5.26%
-0.08
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Ideas Watch: How does Context Therapeutics Inc perform in inflationary periodsMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech Context Therapeutics grants 120,000 stock options to new hires - Stock Titan
CEO Moves: Can Context Therapeutics Inc. stock double in the next year2025 Market Sentiment & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Context Therapeutics Welcomes Andy Pasternak as New Chairman of the Board - MSN
Will Context Therapeutics Inc. stock benefit from automationPortfolio Gains Summary & Risk Adjusted Swing Trade Ideas - Улправда
Context Therapeutics Inc.Common Stock (NQ: CNTX - FinancialContent
User | inyoregister.comContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Pasadena Star News - FinancialContent
Can Context Therapeutics Inc. stock hit record highs againWeekly Earnings Recap & Weekly Top Stock Performers List - Улправда
Will Theranexus Société Anonyme (3VG) stock beat value stocks2025 Big Picture & Proven Capital Preservation Methods - ulpravda.ru
Why Context Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Weekly Breakout Watchlists - Улправда
Why Context Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Sentiment & Daily Profit Maximizing Tips - Улправда
Dow Theory LettersContext Therapeutics Inc.Common Stock (Nasdaq:CNTX) Stock Quote - FinancialContent
Will Enliven Therapeutics Inc. stock see insider buyingWeekly Stock Report & AI Forecasted Stock Moves - ulpravda.ru
Context Therapeutics Highlights T Cell Engager Pipeline Strategy - TipRanks
Context Therapeutics Inc Updates Corporate Presentation on T Cell Engagers - TradingView — Track All Markets
Why Context Therapeutics Inc. stock remains on buy listsGrowth Stock Opportunities & Fast Profit Trading Tips - ulpravda.ru
ALNA pre-market +3.16% on 252,311,606 shares 06 Jan 2026: check catalysts - Meyka
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - Nasdaq
Wondering what's happening in today's after-hours session? - Chartmill
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 UpsideDVLT, UFG, VRME, ARBE More Inside - openPR.com
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside - FinancialContent
Uni-Fuels Holdings Limited (UFG) Stock, Price, News, Quotes, Forecast and Insights - MSN
Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside In Biotech Innovation - DirectorsTalk Interviews
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
MACD Signals Flash Warning for CRP Risk Management Limited StockAnalyst Upgrades & High Yield Portfolio Growth - bollywoodhelpline.com
Raconteur Global Resources Limited Inches Toward Key Resistance — Will It BreakChart Pattern Recognition & Small Budget Wealth Building - bollywoodhelpline.com
BDH Industries Limited Building a Base Near SupportHead and Shoulders Patterns & High Profit Trading Alerts - bollywoodhelpline.com
MACD Signals Flash Warning for Sagar Diamonds Limited StockEarnings Beat Highlights & Free Stock Price Trend Analysis - bollywoodhelpline.com
Jones Trading Initiates Coverage of Context Therapeutics (CNTX) with Buy Recommendation - Nasdaq
Context Therapeutics (NASDAQ:CNTX) Coverage Initiated by Analysts at Jones Trading - MarketBeat
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Aug Reactions: Why Context Therapeutics Inc. stock could benefit from AI revolutionPortfolio Gains Report & AI Powered Market Entry Strategies - moha.gov.vn
Published on: 2025-12-21 00:47:49 - Улправда
Is Context Therapeutics Inc. stock a buy before product launchesJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - Улправда
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Breakouts Watch: How Context Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Community Verified Watchlist Alerts - Улправда
Context Therapeutics Earnings Notes - Trefis
Why Context Therapeutics Inc. stock is a must watch in 2025Trade Signal Summary & Weekly Stock Performance Updates - DonanımHaber
Context Therapeutics Inc. (NASDAQ:CNTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
How Context Therapeutics Inc. stock compares to market leadersWeekly Gains Summary & Weekly Breakout Watchlists - Улправда
Can Forum Energy Technologies Inc. stock attract ESG capital inflowsWeekly Investment Summary & Technical Pattern Alert System - Улправда
Is ABR.PRD stock trading near support levelsWeekly Stock Analysis & Consistent Growth Stock Picks - Улправда
SJVN Limited (533206) Stock Experiences Sudden DipMoving Average Strategies & Free Tremendous Portfolio Expansion - Bollywood Helpline
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards - GlobeNewswire
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7%What's Next? - MarketBeat
Context Therapeutics (NASDAQ:CNTX) Shares Up 8.7% – What’s Next? - Defense World
Oncotelic Therapeutics Study Reveals Context-Dependent Biomarker Significance in Liver and Pancreatic Cancers - citybuzz -
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer - The Manila Times
Unpacking Q3 Earnings: CoStar (NASDAQ:CSGP) In The Context Of Other Data & Business Process Services Stocks - Yahoo Finance
Context Therapeutics Inc (CNTX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
4.73%
0.92%
자본화:
|
볼륨(24시간):